Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.

V, Watson; M, Ryan; CT, Brown; G, Barnett; BW, Ellis; M, Emberton

doi:10.1097/01.ju.0000140957.31325.7f

Public

Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.

Shared by NobleBlocks on Dec 1, 2004 • 12:00 AM UTC

Authors:

Watson V

Ryan M

Brown CT

Abstract

Purpose There are 2 main medical preparations available for lower urinary tract symptoms resulting from benign prostatic hyperplasia (BPH). Choosing between an alpha-blocker and a 5alpha-reductase inhibitor requires trade-offs between their attributes or characteristics. We investigated the relative...

Discussions